Senior living tech company Inspiren secures $100 million Series B funding led by Insight Partners, doubling its customer base to over 230 communities while expanding emergency response and safety technology for elderly residents.
Trump administration launches controversial AI-powered Medicare prior authorization program called WISeR in six states starting January 2026, using algorithms to approve or deny medical procedures like knee surgeries and implants, sparking bipartisan opposition from lawmakers and doctors who fear delayed care and lack of transparency in automated healthcare decisions.
Medical startup Akido Labs deploys AI system ScopeAI to help doctors see 4-5 times more patients by having medical assistants conduct appointments while physicians remotely review AI-generated diagnoses, raising expert concerns about safety, bias, and inadequate testing in clinics serving primarily Medicaid patients.
AI automation threatens repetitive office jobs like transcription and scheduling while careers requiring empathy, physical dexterity, and human judgment—including firefighters, surgeons, therapists, and skilled trades—remain protected, with many roles evolving into human-AI partnerships rather than complete replacement.
AI proves invaluable for seniors in coding, automating routines, prototyping, and bridging knowledge gaps, but lags behind in complex tasks like code review, architecture design, code quality assurance, and security analysis, highlighting its current limitations in software development.
In a groundbreaking AI breakthrough, a new model analyzes routine ECG tests and accurately predicts deadly post-surgery complications like heart attacks and strokes with 85% precision, vastly outperforming current risk assessment methods relied upon by doctors.
Microsoft's CEO foresees AI revolutionizing healthcare through early disease detection, personalizing education, and boosting productivity, while venture capitalists at a16z warn voice AI could displace human labor by automating tasks, as Deepgram's VP highlights speech modeling hurdles and real-world use cases.
The UK and US forge a groundbreaking tech alliance, accelerating AI research for healthcare breakthroughs, unlocking clean energy through nuclear technology, and establishing the North East as an AI Growth Zone, attracting billions in investment and creating thousands of high-paying jobs.
Scholars sound alarms on AI risks like scams and collusion, advocating oversight, ethical guardrails, and pluralism to complement rather than replace human intelligence.
Eli Lilly unveils TuneLab, an AI-driven drug discovery platform backed by a $1 billion research investment, offering biotech companies access to AI models built on Lilly's extensive drug data and joining Lilly Catalyze360's offerings for biotech partners.